Drug Profile
MOR 14
Alternative Names: N-methyldeoxynojirimycin; N-methylmoranolineLatest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Nippon Shinyaku
- Class Anti-ischaemics; Antihyperglycaemics; Antithrombotics; Small molecules
- Mechanism of Action Alpha-glucosidase inhibitors; Plasmin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial thrombosis; Diabetes mellitus; Reperfusion injury